IonQ falls 9.1% after announcing all-stock Elisity acquisition

What happened

IonQ fell 9.1% to $36.27 on October 12, 2026, after announcing an all-stock agreement to acquire Elisity in a deal valued at up to $1.3 billion. The company, IonQ (IONQ), said the transaction could include up to $150 million in performance-based earnouts and that the number of shares to be issued will be determined by a reference price range. The announcement, disclosed in a press release, was reported by CNBC and Barrons.

Market coverage attributed the decline to investor unease about the all-stock structure, which could dilute existing holders. Coverage also noted IonQ disclosed a separate technical milestone around the same time, a development investors treated as secondary to the deal terms.

How big was the move

The stock fell 9.1% on the session, a decline that was 1.9 times a typical daily move for this stock. Trading volume ran 1.3 times its 20-day average, indicating heavier-than-normal activity. The move was 7.7 percentage points worse than the Technology sector median on the day, while the S&P 500 fell 0.1%, making this a large, mostly company-specific move. Over the last five sessions the stock fell 15.6% as the market digested the acquisition details and related coverage.

IonQ opened 2.8% below the previous close on the session, underscoring the abruptness of the reaction. The stock has a beta of 3.28, meaning it tends to move more than the market. In the past five years the stock had 57 sessions with a decline of at least 9.1%; twenty trading days later the median result was a gain of 2.1%, and 29 of 57 were higher.

The technical picture

The stock traded below its key moving averages: 12.7% below its 20-day moving average, 12.2% below its 50-day moving average, and 16.0% below its 200-day moving average. The 50-day average is below the 200-day average, a sign of a weak longer-term trend. The Relative Strength Index (14 days) sat at 35, which is between 30 and 70 and therefore in a neutral range.

The shares were 57.1% below the 52-week high and had fallen 53.2% over one year, leaving the one year versus the S&P 500 at 69.1 percentage points behind the S&P 500. The stock’s 75% annualized over 60 days volatility is lower than 81% of its own readings over five years, a reminder that while the stock moves a lot, recent readings are not unprecedented.

Fundamentals and valuation

For the four quarters through June 30, 2026, IonQ reported revenue of $246.5 million, which grew 370.6% from a year earlier and accelerated from growth of 334.6% in the prior quarter. Gross margin widened to 36.3% from 21.0% a year earlier. Diluted earnings per share for the period were $-4.66. The balance sheet showed net cash of $1.18 billion, while the share count over one year increased by 46.5%, a factor investors flag when assessing dilution from an all-stock takeover.

Free-cash-flow margin was 196.3% and return on invested capital was 15.5%. On valuation, the company had a free-cash-flow yield of 3.2% and a market value of $14.89 billion. Those fundamentals highlight a contrast: exceptional top-line growth and improving gross margin alongside deep losses on a per-share basis and sizable share issuance. PromtFinance scores rank IonQ highly for Growth at 99 (Exceptional) but list Value at 29 (Very weak) and Quality at 26 (Very weak), reflecting the trade-off between rapid expansion and current profitability and valuation metrics.

Earnings and analyst expectations

IonQ last reported on August 5, 2026, with earnings per share of $-0.33 against $-0.29 expected, a result 13.8% below estimates. The company had zero consecutive quarters beating estimates, even though the average surprise over the last four reports was 80.8% above estimates. The stock’s typical two-day reaction after recent reports was that it rose 2.5%.

Analysts supply a consensus price target of $62.75, which is 73.0% above the closing price on October 12, 2026. Six analysts cover the stock; half rate the stock Buy and the consensus rating is Buy. The next scheduled report is November 4, 2026.

What to watch

• The all-stock Elisity acquisition terms and the reference price range that will determine the number of shares to be issued, as disclosed following the October 12 announcement.
• The potential impact of up to $150 million in performance-based earnouts and any forward guidance tied to the transaction, as reported by CNBC and Barrons.
• November 4, 2026, next report date and management commentary on revenue, margins, and cash allocation after the Elisity deal.
• Share count trends following the transaction given the share count over one year increased by 46.5%.
• Short-term price action relative to moving averages and volatility: the stock was 12.2% below its 50-day moving average and showed 75% annualized volatility over 60 days.